Author

Michael Katsikas

Observed names: M Katsikas, M. Katsikas

Observed institutions: National and Kapodistrian University of Athens, Laiko General Hospital of Athens, Metaxa Hospital

OpenAlex ID: A5113640666

A Comparative Study of Intraperitoneal Carboplatin versus Intravenous Carboplatin with Intravenous Cyclophosphamide in Both Arms as Initial Chemotherapy for Stage III Ovarian Cancer

1999 · A. Polyzos, N. Tsavaris, et al. · Oncology · 107

Phase I study of dose-escalated paclitaxel, ifosfamide, and cisplatin (PIC) combination chemotherapy in advanced solid tumours

2000 · C Kosmas, N B Tsavaris, et al. · British Journal of Cancer · 23

Combined Epirubicin, 5-Fluorouracil and Folinic Acid vs No Treatment for Patients with Advanced Pancreatic Cancer: A Prospective Comparative Study

1998 · N. Tsavaris, K. Tentas, et al. · Journal of Chemotherapy · 10

Antiemetic Prophylaxis with Ondansetron and Methylprednisolone vs Metoclopramide and Methylprednisolone in Mild and Moderately Emetogenic Chemotherapy

1999 · Nicholas B Tsavaris, Christos Koufos, et al. · Journal of Pain and Symptom Management · 8

5-Fluorouracil, folinic acid and cisplatin in advanced colorectal cancer

1995 · Nicolas Tsavaris, Kostadinos Tentas, et al. · Anti-Cancer Drugs · 3

Combined Epirubicin, 5-Fluorouracil and Folinic Acid with Allopurinol Protection for Second-Line Treatment of Advanced Gastric Cancer: A Pilot Study

2009 · N. Tsavaris, N. Mylonakis, et al. · Onkologie · 2

Industrial Forum – Industrieforum

2009 · N. Gökbuget, D. Hoelzer, et al. · Onkologie · 2

1999 · Fikri İçli, Ali Arıcan, et al. · Oncology · 1

88p Ros1(+) Lung Adenocarcinoma Treated With Crizotinib – Case Report

2013 · F. Matsouka, D.A. Stamatopoulos, et al. · Lung Cancer

Instructions to Authors

2009 · N. Gökbuget, D. Hoelzer, et al. · Onkologie

Impressum, Vol. 18, No. 4, 1995

2009 · N. Gökbuget, D. Hoelzer, et al. · Onkologie

Book Reviews – Buchbesprechungen

2009 · N. Gökbuget, D. Hoelzer, et al. · Onkologie

1999 · Fikri İçli, Ali Arıcan, et al. · Oncology

Contribution of chemotherapy (CMT) to the survival (S) of patients (P) with advanced gastric cancer (AGC). A retrospective comparative study of patients who received and those who refused treatment (Tx)

1997 · N. Tsavaris, P. Kosmidis, et al. · European Journal of Cancer

Works count: 14

Citation count: 156

H-index: 4

I10-index: 3